Cannabinoid immunoassay reagent kits

Ended Awarded

Contract number
N6854622F6091
Awardee
Awarding agency
Obligated
$6,744

Award facts

Contract value 100% obligated
$6,744.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Norwood, MA 02062, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of the Navy Bureau of Medicine and Surgery awarded Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, a $6,744 firm fixed price delivery order for cannabinoid immunoassay reagent kits. The delivery order was issued against an unidentified contract vehicle and has a period of performance through September 14, 2022. Siemens Healthcare Diagnostics, located in Norwood, Massachusetts, will provide the cannabinoid test kits to the Navy Bureau of Medicine and Surgery to support its medical operations. No set-aside provisions were applied to this award for the immunoassay reagent kits.

Quick answers

Who was awarded contract N6854622F6091?

N6854622F6091 was awarded to Siemens Healthcare Diagnostics Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 6, 2022.

How much is contract N6854622F6091 worth?

The government has obligated $6,744 on N6854622F6091.

Is contract N6854622F6091 an order under another contract?

Yes. N6854622F6091 is a delivery order under N6264521D5015, an indefinite delivery contract.

Was contract N6854622F6091 competed?

The extent of competition for N6854622F6091 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award